Results 1 to 10 of about 1,586 (157)

Clinical Approach to Ocular Cicatricial Pemphigoid [PDF]

open access: yesTürk Oftalmoloji Dergisi, 2023
Objectives:To evaluate the demographic data, ocular and systemic findings, clinical management, and outcomes of patients with ocular cicatricial pemphigoid (OCP).Materials and Methods:The medical records of 11 patients diagnosed as having OCP in the ...
Mukaddes Damla Çiftçi   +7 more
doaj   +5 more sources

Adrenocorticotropic hormone analogue as novel treatment regimen in ocular cicatricial pemphigoid [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports, 2018
Purpose: To report the clinical outcome of a patient with ocular cicatricial pemphigoid, treated with adrenocorticotropic hormone gel. Observations: A 75-year-old female with a biopsy proven ocular cicatricial pemphigoid (OCP) presented with bilateral ...
Yael Sharon, David S Chu
exaly   +4 more sources

Ocular cicatricial pemphigoid. [PDF]

open access: yesRom J Ophthalmol, 2020
Ocular cicatricial pemphigoid (OCP) is an autoimmune ocular disease that causes severe dry eye syndrome, conjunctival scarring with inferior fornix shortening and entropion along with trichiasis. Corneal keratinization and corneal ulcers may lead to permanent vision loss. The therapeutic approach of OCP is a challenging one.
Stan C   +5 more
europepmc   +9 more sources

Implantation of XEN gel stent in a patient with ocular cicatricial pemphigoid [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports, 2023
Purpose: Herein, we report a case of XEN gel stent implantation in a patient with ocular cicatricial pemphigoid that successfully reduced glaucoma topical medication at one year.
Yujia Zhou   +4 more
doaj   +2 more sources

Ocular cicatricial pemphigoid following Dipeptidyl Peptidase-4 inhibitor use: A case report [PDF]

open access: yesAmerican Journal of Ophthalmology Case Reports, 2023
Purpose: To report a rare Ocular Cicatricial Pemphigoid (OCP) case in a patient taking a Dipeptidyl Peptidase-4 Inhibitor (DPP-4 inhibitor), a medication used for the management of type 2 diabetes, for at least six years. Observations: A 64-year-old male
Akifumi Matsumoto   +4 more
doaj   +2 more sources

An elderly Hispanic male with mucosal erosions

open access: yesJEADV Clinical Practice, 2023
JEADV Clinical Practice, Volume 2, Issue 4, Page 1013-1015, December 2023.
Juan D. Dufflart Ocampo   +5 more
doaj   +2 more sources

Ocular cicatricial pemphigoid (Review). [PDF]

open access: yesExp Ther Med, 2020
Ocular cicatricial pemphigoid is a particular form of mucous membrane pemphigoid and it is characterized by a chronic bilateral conjunctivitis with relapsing-remitting periods. Without therapy 75% of the cases develop visual loss due to major ocular complications (e.g.
Branisteanu DC   +9 more
europepmc   +4 more sources

Incidence, prevalence, and demographic characteristics of ocular cicatricial pemphigoid in Colombia: data from the National Health Registry 2009-2019 [PDF]

open access: yesInternational Journal of Ophthalmology, 2021
AIM: To provide an epidemiological characterization of ocular cicatricial pemphigoid (OCP) in Colombia. METHODS: We conducted a cross-sectional study using SISPRO.
Carlos Cifuentes-González   +4 more
doaj   +2 more sources

Ocular cicatricial pemphigoid [PDF]

open access: yesAustralasian journal of optometry, The, 2003
Ocular cicatricial pemphigoid is a chronic progressive immunological disease, although acute inflammatory episodes may occur. Typically, it leads to fornix foreshortening, symblepharon and dry eye problems. In the end stage, the cornea is severely affected, resulting in serious vision loss.
Graham A Lee
exaly   +6 more sources

Rituximab Therapy in Refractory Ocular Cicatricial Pemphigoid: A Case Report [PDF]

open access: yesReports
Background and Clinical Significance: Ocular cicatricial pemphigoid (OCP) is a rare autoimmune disease affecting the conjunctiva and oral mucosa. Chronic inflammation causes conjunctival scarring, leading to symblepharon, trichiasis, corneal damage, and ...
Sania Vidas Pauk   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy